Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pathology consultation on evaluating prognosis in incidental monoclonal lymphocytosis and chronic lymphocytic leukemia.

American journal of clinical pathology - 1 Jun 2013

Siddon Alexa J, Rinder Henry M

Abstract excerpt

Chronic lymphocytic leukemia (CLL) is a monoclonal B-cell lymphoproliferative disorder generally characterized by an indolent clinical course. However, some patients with CLL will have more aggressive disease progression, and identifying that subgroup may be important for early, or perhaps more a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ADP-ribosyl Cyclase 1
Share to beta 2-Microglobulin
Share to Gene Rearrangement, B-Lymphocyte

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunoglobulin Heavy Chains

Share to Immunoglobulin Variable Region

Share to Incidental Findings

Share to Lymphocytosis

Share to ZAP-70 Protein-Tyrosine Kinase

Source

Identifiers

PMID: 23690112
DOI: 10.1309/AJCPLIR4GZWX3XKA

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23690112-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pathology consultation on evaluating prognosis in incidental monoclonal lymphocytosis and chronic lymphocytic leukemia.PMID 23690112Read ↗

Management of patients with chronic lymphocytic leukemia with a high risk of adverse outcome: the Mayo Clinic approach.Semantic proximity Read ↗

Clinical prognostic biomarkers in chronic lymphocytic leukemia and diffuse large B-cell lymphoma.Semantic proximity Read ↗

iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL.Semantic proximity Read ↗

The future of laboratory testing in chronic lymphocytic leukaemia.Semantic proximity Read ↗

Diagnostic and prognostic molecular pathology of lymphoid malignancies.Semantic proximity Read ↗

Novel prognostic gene mutations identified in chronic lymphocytic leukemia and their impact on clinical practice.Semantic proximity Read ↗

Monoclonal B-cell lymphocytosis: a brief review for general clinicians.Semantic proximity Read ↗

Occult B-cell lymphoproliferative disorders.Semantic proximity Read ↗

Prognostic markers and their clinical applicability in chronic lymphocytic leukemia: where do we stand?Semantic proximity Read ↗

Pathology of chronic lymphocytic leukemia: an updateSemantic proximity Read ↗

Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia.Semantic proximity Read ↗

Monoclonal B-cell lymphocytosis: a reappraisal of its clinical implications.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.